Items where authors include "Vanderlinden, A."

Article

Rominiyi, O. orcid.org/0000-0002-9724-0224, McGarrity-Cottrell, C., Myers, K.N. orcid.org/0000-0002-1951-4744 et al. (16 more authors) (2024) Ex-vivo models of post-surgical residual disease in human glioblastoma [version 1; peer review: awaiting peer review]. F1000Research, 13. 1316. ISSN 2046-1402

Derby, S., Dutton, L., Strathdee, K.E. et al. (27 more authors) (2024) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology, 26 (4). pp. 625-639. ISSN 1522-8517

Jones, C.G. orcid.org/0000-0003-2958-8322, Vanderlinden, A., Rominiyi, O. orcid.org/0000-0002-9724-0224 et al. (1 more author) (2024) Development and optimisation of Tumour Treating Fields (TTFields) delivery within 3D primary glioma stem cell-like models of spatial heterogeneity. Cancers, 16 (5). 863. ISSN 2072-6694

Vanderlinden, A., Jones, C.G. orcid.org/0000-0003-2958-8322, Myers, K.N. et al. (2 more authors) (2023) DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. British Journal of Cancer, 129. 1840. ISSN 0007-0920

Carmell, N., Rominiyi, O. orcid.org/0000-0002-9724-0224, Myers, K.N. et al. (9 more authors) (2021) Identification and validation of ERK5 as a DNA damage modulating drug target in glioblastoma. Cancers, 13 (5). 944. ISSN 2072-6694

Rominiyi, O., Vanderlinden, A., Clenton, S.J. et al. (3 more authors) (2021) Tumour treating fields therapy for glioblastoma : current advances and future directions. British Journal of Cancer, 124. pp. 697-709. ISSN 0007-0920